About Readout AI

ReadoutAI automates the analysis of clinical trial data through AI-driven workflows that include data cleaning, statistical analysis, and report generation. This technology reduces the time required for these tasks by up to 85%, enabling faster insights and more efficient trial management.

```xml <problem> Clinical trial data analysis is a time-consuming process, often requiring manual data cleaning, statistical analysis, and report generation. These tasks can delay insights, hinder efficient trial management, and increase the overall cost of bringing therapies to market. </problem> <solution> ReadoutAI offers an AI-powered platform that automates clinical trial data analysis, significantly reducing the time and effort required for data cleaning, statistical analysis, and report generation. The platform streamlines workflows across the trial lifecycle, from recruitment funnel analysis to clinical study report (CSR) generation. By leveraging AI and machine learning, ReadoutAI enables faster insights, improved efficiency, and accelerated therapy development. The platform prioritizes data privacy, ensuring that uploaded data is deleted after analysis. </solution> <features> - Automated data cleaning and validation to identify and flag data errors. - AI-driven statistical analysis, including descriptive statistics, hypothesis testing, and regression analysis. - Automated generation of tables, graphs, and reports in ICH E3 format. - Recruitment funnel analysis to identify bottlenecks and improve patient enrollment. - Compliance analysis to monitor patient adherence to study protocols. - Automated demographics analysis to ensure diversity in trial populations. - Secure data handling with data deletion after analysis to protect patient privacy. </features> <target_audience> ReadoutAI primarily targets pharmaceutical companies, biotech firms, and clinical research organizations (CROs) seeking to accelerate clinical trial analysis and improve efficiency. </target_audience> ```

What does Readout AI do?

How much funding has Readout AI raised?

Readout AI has raised $1.7M.

Funding

$1.7M

Employees

3 employees

Investors

Necessary

Readout AI

3300+ followers

Updated 2 months ago

Funding

$1.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Clinical trial data analysis is a time-consuming process, often requiring manual data cleaning, statistical analysis, and report generation. These tasks can delay insights, hinder efficient trial management, and increase the overall cost of bringing therapies to market.

Solution

ReadoutAI offers an AI-powered platform that automates clinical trial data analysis, significantly reducing the time and effort required for data cleaning, statistical analysis, and report generation. The platform streamlines workflows across the trial lifecycle, from recruitment funnel analysis to clinical study report (CSR) generation. By leveraging AI and machine learning, ReadoutAI enables faster insights, improved efficiency, and accelerated therapy development. The platform prioritizes data privacy, ensuring that uploaded data is deleted after analysis.

Target Audience

ReadoutAI primarily targets pharmaceutical companies, biotech firms, and clinical research organizations (CROs) seeking to accelerate clinical trial analysis and improve efficiency.

Features

Automated data cleaning and validation to identify and flag data errors.
AI-driven statistical analysis, including descriptive statistics, hypothesis testing, and regression analysis.
Automated generation of tables, graphs, and reports in ICH E3 format.
Recruitment funnel analysis to identify bottlenecks and improve patient enrollment.
Compliance analysis to monitor patient adherence to study protocols.
Automated demographics analysis to ensure diversity in trial populations.
Secure data handling with data deletion after analysis to protect patient privacy.